SRGAP1
Chr 12ADSomaticSLIT-ROBO Rho GTPase activating protein 1
Also known as: ARHGAP13, NMTC2
SRGAP1 encodes a GTPase-activating protein that inactivates CDC42 and RhoA small GTPases and regulates neuronal migration through interaction with ROBO1 in response to SLIT signaling. Mutations cause nonmedullary thyroid cancer type 2 with autosomal dominant inheritance, though somatic mutations also occur. The gene is highly constrained against loss-of-function variants (pLI 0.998, LOEUF 0.267), suggesting intolerance to protein loss.
Population Genetics & Constraint
gnomAD v4 — loss-of-function & missense intolerance
Highly LoF-intolerant (top ~10% of genes)
Moderately missense-constrained (top ~2.5%)
The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).
Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.
ClinVar Variant Classifications
0 submitted variants in ClinVar
Protein Context — Lollipop Plot
SRGAP1 · protein map & ClinVar variants
Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.
3D Protein StructureAlphaFold
External Resources
Links to major genomics databases and tools
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
No active trials found for this gene.
Search ClinicalTrials.gov →External Resources
Links to major genomics databases and tools